Dingdang Health Technology Group Ltd. (09886.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−7.7x

Market Cap

HKD 1.10B

MomentumView details →

1D Return

−5.56%

YTD Return

−20.56%

RSI (14)

54.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−7.7x

Market Cap

HKD 1.10B

RSI (14)

54.1

MomentumView details →

1D Return

−5.56%

YTD Return

−20.56%

ProfitabilityView details →

Gross Margin

35.26%

Net Margin

−1.00%

EBITDA Margin

−0.32%

ROE (TTM)

−2.95%

ROA (TTM)

−1.73%

Asset Turnover

1.72x

GrowthView details →

Revenue YoY

+4.67%

EPS YoY

+86.80%

FCF YoY

—

Revenue CAGR 3Y

+4.13%

EPS CAGR 3Y

+86.54%

EBITDA YoY

+90.21%

EarningsView details →

EPS (Actual)

−HKD 0.06

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.17x

Current Ratio

2.28x

Quick Ratio

1.59x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

4.89B

Net Income (TTM)

−49.02M

Op. CF (TTM)

—

Next earningsMar 31, 2027 →

Latest newsMore news →

Dingdong Health reported interim results for the six months ended June 2026, with revenue of RMB 2.409 billion, up 3.5% year-on-year, and a widened net loss of RMB 64.37 million.14d ago

Similar companies

Natural Beauty Bio-Technology Limited00157.HK Edgewell Personal Care CompanyEPC Soft International Group Ltd.02569.HK Helen of Troy LimitedHELE Spectrum Brands Holdings, Inc.SPB ST瑞贝卡600439.SH Find similar companies →

Latest newsMore news →

Dingdong Health reported interim results for the six months ended June 2026, with revenue of RMB 2.409 billion, up 3.5% year-on-year, and a widened net loss of RMB 64.37 million.14d ago